Sildosin as a non-hormonal birth control for men
This study tests a drug called sildosin as a possible non-hormonal birth control for men. If you are a sexually active man not currently using contraception, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man who is sexually active
- You cannot be taking any oral contraceptives (birth control pills)
- Your female partner must not be using any form of contraception
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new non-hormonal male contraceptive pill called NLS-133. It is taken just before sex and could help give men more control over family planning.
This study tests a daily medication called silodosin to see how well it improves urinary symptoms and how it affects sexual function in men with an enlarged prostate.
This study compares three forms of sildenafil — a common erectile dysfunction medication — to see how well the body absorbs them after a high-fat meal. It is an early-stage trial in healthy men to check for safety and how the drugs work.
This study tests a new form of sildenafil (the active ingredient in Viagra) for treating erectile dysfunction in men. It aims to see how well it works and how safe it is, and you'll need to track your progress using a smartphone app.
This study tests a combination pill containing leucine (an amino acid), sildenafil (the erectile dysfunction drug), and metformin (a diabetes drug) to see if it can lower blood pressure. You might join if you have mild high blood pressure and are not taking too many other blood pressure medications.
This study compares a new once-daily pill to an existing medication for men with an enlarged prostate. It aims to see if the new pill is better at improving urinary symptoms and urine flow.
Hear when a new Contraception Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.